Pharmaceuticals & Biotechnology

Marie Oh Huber

Marie Oh Huber has an extensive track record as a business and legal/regulatory leader in three large, global public companies with significant experience in strategic and operational issues, digital economy, Internet, eCommerce, data sharing and security, online shopping/retail, M&A, corporate governance, shareholder relations, legal, enterprise risk management, regulatory, financial literacy, … Read more

Stacy J. Kanter

Stacy J. Kanter is an Independent Board Director and former Head of the Global Capital Markets practice at Skadden, Arps, Slate, Meagher & Flom. Under Ms. Kanter’s leadership, the Capital Markets business nearly doubled, and the practice significantly enhanced its position as a market and thought leader, including being named … Read more

Laurie B. Keating

Laurie is an enterprise-wide, strategic leader with entrepreneurial insights and three decades of executive management, Board and Board counselling experience in diverse settings. She has expertise in M&A, business development, finance, governance, quality, government affairs, compliance, and human resources, in addition to business law, intellectual property and litigation.

She served … Read more

Suzanne Rich Folsom

Suzanne Rich Folsom is an accomplished board member and results-oriented C-Suite leader with broad global experience and a successful track record of driving transformation at public and private companies of all sizes and across diverse industries, especially during periods of heightened regulatory attention and intense public scrutiny.

Ms. Folsom is … Read more

Ashley C. Gould

Ashley C. Gould has over two decades of professional experience, during which she has been a member of executive teams of private and public companies in the technology and life sciences fields, advisor to emerging companies as well as investment funds and a member of not-for-profit boards.

As a trusted … Read more

Meena L. Elliott

Meena Elliott is a C-suite executive with an expansive and deep breadth and depth of experience. As President of Kiverdi, Inc. she leads the company with overall profit and loss accountability, in addition to her scaling and fundraising work. Kiverdi, Inc. is a mid-stage biotech company and parent company of … Read more

Connie R. Collingsworth

Connie Collingsworth is a board member of Banner Corporation, a publicly-traded bank holding company, with $16 billion in assets, and chairs the Governance/Nominating Committee; and Premera Blue Cross, one of the largest health plans in the Pacific Northwest and chairs the Compensation Committee. She has served on Risk and Investment … Read more

Linda L. Addison

Linda Addison is an experienced independent director and chief executive. She is Lead Independent Director of Globe Life Inc. (NYSE: GL), an S&P 500 company. She is also an independent board member of KPMG LLP, the Big 4 US audit, tax and advisory firm, a privately-owned partnership with annual revenues … Read more

Susan H. Alexander

Susan H. Alexander is Executive Vice President, Chief Legal Officer and Corporate Secretary of Biogen Idec. Biogen Idec is a global Fortune 500 biotechnology company focused on discovering, developing and marketing therapies for the treatment of neurological disorders and other serious diseases. Ms. Alexander is a member of the executive … Read more

Roya Behnia

A public company c-suite executive for many years, Ms. Behnia has advised boards of directors and senior management on a wide array of strategic matters in a global environment, including geographic expansion, strategic/business model transformation, M&A and complex commercial alliances, executive compensation, risk alignment, data security, crisis situations, and business … Read more